Transformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL Patients

por Nydegger, Anna, Novak, Urban, Kronig, Marie-Noëlle, Legros, Myriam, Zeerleder, Sacha, Banz, Yara, Bacher, Ulrike, Pabst, Thomas
Publicado 2021

Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome

por Lakomy, Tim, Akhoundova, Dilara, Nilius, Henning, Kronig, Marie-Noëlle, Novak, Urban, Daskalakis, Michael, Bacher, Ulrike, Pabst, Thomas
Publicado 2023

Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients

por Sanoyan, Dilara Akhoundova, Seipel, Katja, Bacher, Ulrike, Kronig, Marie-Noelle, Porret, Naomi, Wiedemann, Gertrud, Daskalakis, Michael, Pabst, Thomas
Publicado 2023

Experiences with Next-Generation Sequencing in Relapsed Acute Myeloid Leukemia: A Patient Case Series

por Flach, Johanna, Shumilov, Evgenii, Porret, Naomi, Shakhanova, Inna, Legros, Myriam, Kronig, Marie-Noëlle, Joncourt, Raphael, Bacher, Ulrike, Pabst, Thomas
Publicado 2020

Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation

por Shumilov, Evgenii, Shakhanova, Inna, Flach, Johanna, Schmidt, Nicole, Buerki, Susanne, Legros, Myriam, Kronig, Marie-Noëlle, Ofran, Yishai, Gerull, Sabine, Medinger, Michael, Taleghani, Behrouz Mansouri, Passweg, Jakob, Halter, Jörg, Bacher, Ulrike, Pabst, Thomas
Publicado 2021